Endoscopic Submucosal Dissection Registry
ESDREG
1 other identifier
observational
200
1 country
1
Brief Summary
This is a patient registry for all cases of pre-neoplastic or early neoplastic digestive tract lesions treated with curative intention by endoscopic submucosal dissection (ESD) technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
September 3, 2023
CompletedFirst Posted
Study publicly available on registry
September 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2031
November 12, 2024
November 1, 2024
10 years
September 3, 2023
November 9, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of curative resection
through study completion, an average of 1 year
Secondary Outcomes (1)
Rate of R0 resection
through study completion, an average of 1 year
Other Outcomes (2)
Rate of perforation
30 days
Rate of delayed bleeding
30 days
Interventions
Endoscopic injection of fluid into the gastrointestinal submucosal space followed by endoscopic knife dissection around and under the lesion so as to remove the lesion specimen in one piece with lesion free resection margins.
Eligibility Criteria
Patients diagnosed at or referred to Gastroenterology Clinic, University of Medicine and Pharmacy, "Agrippa Ionescu" Hospital, Bucharest, Romania
You may qualify if:
- epithelial pre-neoplastic (eg. adenoma, dysplasia) lesion on the esophageal, gastric, duodenal or colorectal mucosa
- non-epithelial (eg. neuroendocrine tumor) lesion on the esophageal, gastric, duodenal or colorectal mucosa
- age \> 18 years old
- informed consent
You may not qualify if:
- age \< 18 years old
- no informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
"Agrippa Ionescu" Hospital
Bucharest, Romania
Biospecimen
Resected specimens of the gastrointestinal tract, fixed in formalin
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mihai L Ciocirlan, Associate Professor
Carol Davila University of Medicine and Pharmacy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor (Associate Professor)
Study Record Dates
First Submitted
September 3, 2023
First Posted
September 13, 2023
Study Start
January 1, 2021
Primary Completion (Estimated)
January 1, 2031
Study Completion (Estimated)
January 1, 2031
Last Updated
November 12, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share